TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Slide background
Slide background
Posted February 26, 2020

BERLIN, Germany—Korsch, a global tablet press manufacturer and supplier, has appointed Bicor Technologies as its exclusive sales and service partner in Mexico, offering the full line of Korsch equipment. Bicor will employ local service engineers with full Korsch factory training to provide service and maintenance and run a Korsch OEM spare-parts inventory warehouse in Mexico City.

Posted February 25, 2020

THUN, Switzerland—Hoffmann Neopac, a global supplier of metal and plastic packaging for the pharmaceutical and fast-moving consumer goods industries, has acquired Trivium Packaging’s production lines for hinged-lid cans in Deventer, Netherlands. This acquisition strengthens Hoffmann’s market presence for specialty cans in Europe.

Posted February 24, 2020

WAIBLINGEN, Germany—Bosch Packaging Technology is now Syntegon Technology and is an independent enterprise from Bosch. The renamed company will focus on intelligent and sustainable technologies for the pharmaceutical and food industries. Syntegon Technology employs 6,100 people at more than 30 locations worldwide.

Posted February 23, 2020

PHILADELPHIA, PA—PCI Pharma Services, a pharmaceutical and biopharmaceutical CDMO, has announced an expansion of its Tredegar facility in Wales, UK, to strengthen its high-potency drug manufacturing and development capabilities including both clinical and commercial supply. The investment involves expanding the contained oral solid dosage form manufacturing facility to double the large-scale granulation and fluid-bed drying capacity. The expansion will also include additional space for new potent handling capabilities, additional analytical capacity, and a small-scale processing area to allow early stage non-GMP processing and formulation. The expansion is expected to be completed in late 2021.

Posted February 22, 2020

ALLENDALE, NJ—Kraemer, a manufacturer of tablet dedusters and related equipment, is celebrating 45 years in business. The company invented the first vertical tablet deduster in 1975 to address production problems caused by dusty tablets in the pharmaceutical industry. The company’s first deduster model, the E79, can still be found in many tablet production suites today.

Posted February 21, 2020

WICKLIFFE, OH—Lubrizol Life Science Health has acquired Lipofoods, Barcelona, Spain, which was previously part of the Lubrizol Life Science Beauty business. Lipofoods Nutraceutical Ingredients will serve as the umbrella brand for Lubrizol’s new nutraceutical division and includes all existing brands and product platforms for microencapsulated minerals and botanicals. The nutraceutical division will use Lubrizol’s internal capabilities for improving bioavailability and oral delivery for its portfolio of active ingredients.

Posted February 20, 2020

SOMERSET, NJ—Catalent, a pharmaceutical CDMO, has purchased a Bristol-Myers Squibb (BMS) manufacturing and packaging facility in Anagni, Italy. The 305,000-square-foot facility’s capabilities include primary and secondary packaging solutions, including serialization, to support product launches for oral solid, sterile, and biologic products. Catalent will continue to manufacture the existing BMS product portfolio currently produced at the site.

Posted February 19, 2020

ST. LOUIS, MO—TricorBraun, a packaging manufacturer, has acquired rigid packaging distributor Packaging Solutions, Minneapolis, MN, strengthening TricorBraun’s presence in Minneapolis and providing an additional warehouse to support future growth. Current Packaging Solutions team members, including owners Doug and John Greenberg, will remain with TricorBraun and continue to work out of the Minneapolis location.

Posted February 8, 2020

PHILADELPHIA, PA—PCI Pharma Services (PCI), a pharmaceutical and biopharmaceutical global supply chain solutions provider, has acquired Bellwyck Pharma Services, Toronto, Canada, a primary and secondary packaging and labeling provider for clinical trial and commercial drug markets. The acquisition will add four GMP-compliant facilities to PCI’s existing network, bringing the total to 25 GMP facilities in North America, Europe, and Asia Pacific. Additionally, the acquisition will allow PCI to establish a market presence in Canada and Germany. This is PCI’s third acquisition outside of the US in the last three years.